Home/Filings/4/0001493152-20-017159
4//SEC Filing

Drechsler Andrew T 4

Accession 0001493152-20-017159

CIK 0001695357other

Filed

Sep 1, 8:00 PM ET

Accepted

Sep 2, 5:00 PM ET

Size

5.1 KB

Accession

0001493152-20-017159

Insider Transaction Report

Form 4
Period: 2020-09-02
Drechsler Andrew T
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2020-09-02$11.72/sh+2,000$23,44020,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.71 to $11.73, inclusive. The reporting person undertakes to provide to Provention Bio, Inc., any security holder of Provention Bio, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Documents

1 file

Issuer

Provention Bio, Inc.

CIK 0001695357

Entity typeother

Related Parties

1
  • filerCIK 0001324734

Filing Metadata

Form type
4
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 5:00 PM ET
Size
5.1 KB